Key Players in Motion Sickness Drugs Market Include GlaxoSmithKline, Novartis, and Teva Pharmaceuticals

News provided by

Oct 26, 2023, 20:15 ET

DUBLIN, Oct. 26, 2023 /PRNewswire/ -- The "Global Motion Sickness Drugs Market 2023-2027" report has been added to ResearchAndMarkets.com's offering.

The global motion sickness drugs market is poised for substantial growth, with a projected increase of USD 136.49 million during the period 2022-2027, at a steady CAGR of 4.43%.

This forecast is outlined in the comprehensive report on the motion sickness drugs market, which provides an all-encompassing analysis, including market size, trends, growth drivers, challenges, and an exhaustive vendor analysis, featuring approximately 25 leading companies in the sector.

The report presents an up-to-date analysis of the current market scenario, highlighting the latest trends, key drivers, and the overall market environment. The motion sickness drugs market is being driven by factors such as the widespread availability of over-the-counter (OTC) drugs, the diverse range of dosage forms for motion sickness drugs, and the surging growth of the global travel and tourism industry.

Segmentation of the motion sickness drugs market includes:

By Product

Antihistamines
Anticholinergics

By Distribution Channel

Offline
Online

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

One of the primary drivers fueling the motion sickness drugs market growth is the emergence of nauseogenic information technology. Additionally, the increasing penetration of online channels and the expanding research on psychosomatic disorders are expected to contribute to substantial market demand in the coming years.

The report on the motion sickness drugs market encompasses the following key areas:

Motion Sickness Drugs Market Sizing
Motion Sickness Drugs Market Forecast
Motion Sickness Drugs Market Industry Analysis

The report provides a comprehensive vendor analysis, featuring prominent industry players, including:

Abbott Laboratories
Amneal Pharmaceuticals Inc.
Baxter International Inc.
CVS Health Corp.
DM Pharma Marketing Pvt. Ltd.
GlaxoSmithKline Plc
Hylands
Lupin Ltd.
Merck KGaA
Myungmoon Pharm Co. Ltd.
Novartis AG
Perrigo Co. Plc
Prestige Consumer Healthcare Inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Tivic Health Systems Inc.
Viatris Inc.
WellSpring Pharmaceutical Corp.
Zenomed Healthcare Pvt. Ltd.
Zydus Lifesciences Ltd.

With an expanding motion sickness drugs market, the future holds significant potential for growth and innovation in this sector. Market stakeholders are encouraged to utilize these insights to make informed decisions and contribute to the advancement of motion sickness treatment.

For more information about this report visit https://www.researchandmarkets.com/r/65vr7f

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets